---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-26-000002"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:56:06.226049+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Tarsus Pharmaceuticals furnishes corporate presentation; no material updates identified

## Summary
- Corporate presentation published January 12, 2026, on company website.
- Presentation highlights XDEMVY eye care product; no new financial or clinical data provided.
- Routine Regulation FD disclosure; no guidance changes or strategic announcements.
- Furnished excerpt does not contain specific numbers or events beyond product branding.

## SEC filing metadata
- accession: 0001819790-26-000002
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000002/0001819790-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000002/tars-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-26-000002
- JSON: https://secwatch.observer/filing/0001819790-26-000002.json
- Plain text: https://secwatch.observer/filing/0001819790-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.